WITTE OWEN N. has filed 3 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 95400 shares of Allogene Therapeutics, Inc. ($ALLO) on June 18, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 18, 2025 | Allogene Therapeutics, Inc. | $ALLO | WITTE OWEN N. | Director | A | Restricted Stock Unit | 95400 | $0.00 | 95,400.0000 | 217,264,738 | 9999.99% | 0.04% |
| June 5, 2024 | Allogene Therapeutics, Inc. | $ALLO | WITTE OWEN N. | Not found | A | Stock Option (Right to buy) | 191082 | $0.00 | 191,082.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2023 | Allogene Therapeutics, Inc. | $ALLO | WITTE OWEN N. | Not found | A | Common Stock | 74561 | $0.00 | 292,832.0000 | 0 | 34.16% | 0.00% |